Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia.

Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia.

Bibliographic Details
Main Authors:	Singhal, S, Powles, R, Horton, C, Shepherd, V, Meller, S, Pinkerton, C, Hale, G, Waldmann, H, Treleaven, J, Mehta, H
Format:	Journal article
Published:	1996

Similar Items

Autografting with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia.
by: Treleaven, J, et al.
Published: (1996)

Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia.
by: Tiley, C, et al.
Published: (1993)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
by: Cobbold, S, et al.
Published: (1990)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
by: Cobbold, S, et al.
Published: (1990)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
by: Hale, G, et al.
Published: (1985)

Monoclonals and marrow transplants.
by: Waldmann, H, et al.
Published: (1986)

Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
by: Hale, G, et al.
Published: (1998)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
by: Waldmann, H, et al.
Published: (1985)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
by: Hale, G, et al.
Published: (1989)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
by: Waldmann, H, et al.
Published: (1985)

HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION - INVIVO CONDITIONING WITH MONOCLONAL-ANTIBODIES
by: Fasth, A, et al.
Published: (1988)

In vivo 'purging' of residual disease in CLL with Campath-1H.
by: Dyer, M, et al.
Published: (1997)

RAT MONOCLONAL-ANTIBODIES TO PREVENT G-VS-H AND H-VS-G REACTIONS IN BONE-MARROW TRANSPLANTATION
by: Waldmann, H, et al.
Published: (1986)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
by: Naparstek, E, et al.
Published: (1999)

Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance.
by: Cobbold, S, et al.
Published: (1986)

Long-term outcome after marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia using cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies
by: Gupta, V, et al.
Published: (2005)

Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.
by: Hale, G, et al.
Published: (1983)

The CAMPATH-1 antigen (CDw52).
by: Hale, G, et al.
Published: (1990)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
by: Bindon, C, et al.
Published: (1985)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
by: Naparstek, E, et al.
Published: (1993)

Favourable impact on acute and chronic graft-versus-host disease with cyclophosphamide and in-vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anaemia.
by: Gupta, V, et al.
Published: (2004)

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
by: Gupta, V, et al.
Published: (2004)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
by: Bindon, C, et al.
Published: (1988)

In vivo/ex vivo T-cell depletion with anti-CD52 monoclonal antibodies: long-term results in patients with acute leukaemia in CR1
by: Bunjes, D, et al.
Published: (2004)

Specificity of monoclonal antibody Campath-1.
by: Hale, G, et al.
Published: (1988)

Advantages of rat monoclonal antibodies.
by: Clark, M, et al.
Published: (1983)

The repopulation capacity of bone marrow grafts following pretreatment with monoclonal antibodies against T lymphocytes in rhesus monkeys.
by: Gerritsen, W, et al.
Published: (1988)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
by: Waldmann, H, et al.
Published: (2001)

Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen.
by: Xia, M, et al.
Published: (1993)

MONOCLONAL-ANTIBODIES CAN BE USED TO CONTROL BOTH GVHD AND REJECTION IN MOUSE MODELS OF BONE-MARROW TRANSPLANTATION
by: Cobbold, S, et al.
Published: (1985)

Availability of Campath-1 antibodies for bone marrow transplantation.
by: Hale, G, et al.
Published: (1995)

Interaction of rat monoclonal antibodies with human killer cells.
by: Clark, M, et al.
Published: (1985)

Separation of hemopoietic cells from adult mouse marrow by use of monoclonal antibodies.
by: Hoang, T, et al.
Published: (1983)

Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
by: Cobbold, S, et al.
Published: (1986)

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).
by: Lundin, J, et al.
Published: (2002)

Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting.
by: Morgan, G, et al.
Published: (1986)

INTERACTION OF RAT MONOCLONAL-ANTIBODIES WITH HUMAN KILLER CELLS (K-CELLS)
by: Hale, G, et al.
Published: (1984)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
by: Lockwood, C, et al.
Published: (1993)